Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatch or journal? new study tests two ways to ease anxiety and depression

NCT ID NCT07607834

Symptom relief Sponsor: Asia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two ways to help adults with anxiety and depression become more aware of their emotions and learn to rethink them. One group used a smartwatch to track emotions in real time, while the other reflected on their day each evening. Over six weeks, both groups showed improvements in anxiety, depression, and emotional well-being. The study was small and early-stage, so more research is needed to confirm the results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Jan 2024

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 45 years. * Self-reported co-occurring anxiety and depressive symptoms. * Score of 8 or above on the Chinese version of the Beck Anxiety Inventory. * Score between 14 and 28 on the Chinese version of the Beck Depression Inventory-II. * Ability to provide written informed consent and complete the study procedures. Exclusion Criteria: * Illegal substance use. * Excessive alcohol or caffeine consumption, defined as more than four caffeinated beverages or four cans of beer per day. * Major psychiatric disorders or cognitive impairment, such as schizophrenia or neurocognitive disorders. * Current psychiatric medication use. * Ongoing psychological or psychiatric treatment. * Pregnancy or current responsibility for caring for an infant. * Severe depressive symptoms, defined as a Beck Depression Inventory-II score of 29 or above.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety symptoms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression Emotional Regulation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety symptoms Depressive symptoms Emotion regulation

Contacts and locations

Locations

  • 亞洲大學

    Taichung, 41354, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.